Oramed Pharmaceuticals
ORMP
#9088
Rank
ยฃ90.37 M
Marketcap
ยฃ2.27
Share price
4.66%
Change (1 day)
17.70%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2025 (TTM): -ยฃ4.03 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are ยฃ2 Million. In 2024 the company made an earning of ยฃ0.26 Million a decrease over its 2023 earnings that were of ยฃ5.32 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ4.03 Million-1624.81%
2024 ยฃ0.26 M-95.05%
2023 ยฃ5.32 M-119.45%
2022 -ยฃ27.38 Million39.17%
2021 -ยฃ19.67 Million73.93%
2020 -ยฃ11.31 Million18.53%
2019 -ยฃ9.54 Million-16.62%
2018 -ยฃ11.45 Million38.32%
2017 -ยฃ8.28 Million12.51%
2016 -ยฃ7.36 Million25.01%
2015 -ยฃ5.89 Million18.18%
2014 -ยฃ4.98 Million39.72%
2013 -ยฃ3.57 Million46.4%
2012 -ยฃ2.44 Million128.32%
2011 -ยฃ1.07 Million-51.47%
2010 -ยฃ2.2 Million35.21%
2009 -ยฃ1.63 Million
2007 -ยฃ2.56 Million607.04%
2006 -ยฃ0.37 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-ยฃ0.39 Billion 12,138.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
ยฃ15.57 B-491,978.24%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
ยฃ6.80 B-214,830.06%๐Ÿ‡ซ๐Ÿ‡ท France
Compugen
CGEN
-ยฃ20.6 Million 550.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Lexicon Pharmaceuticals
LXRX
-ยฃ51.25 Million 1,518.17%๐Ÿ‡บ๐Ÿ‡ธ USA